Nonfunctional Well-differentiated Neuroendocrine Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-04-10
Clinical Trial Update: AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm [Phase 2]
Phase 2 AMT-PET monitoring study evaluating telotristat etiprate in participants with metastatic neuroendocrine neoplasms has completed and …